LIVI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 28.611
EU - Europa 18.589
AS - Asia 13.251
SA - Sud America 1.714
Continente sconosciuto - Info sul continente non disponibili 501
AF - Africa 341
OC - Oceania 201
AN - Antartide 2
Totale 63.210
Nazione #
US - Stati Uniti d'America 28.088
RU - Federazione Russa 6.184
IT - Italia 4.358
SG - Singapore 3.789
CN - Cina 3.395
PL - Polonia 2.774
HK - Hong Kong 1.927
BR - Brasile 1.376
IE - Irlanda 1.318
VN - Vietnam 1.233
KR - Corea 1.112
SE - Svezia 1.103
FR - Francia 678
DE - Germania 644
FI - Finlandia 469
IN - India 426
GB - Regno Unito 363
CA - Canada 333
BD - Bangladesh 295
JO - Giordania 252
UA - Ucraina 202
AU - Australia 196
ID - Indonesia 149
JP - Giappone 141
ES - Italia 125
AR - Argentina 124
TR - Turchia 95
NL - Olanda 94
IQ - Iraq 84
MX - Messico 79
CH - Svizzera 77
CI - Costa d'Avorio 61
ZA - Sudafrica 55
EC - Ecuador 52
NG - Nigeria 52
PK - Pakistan 48
BE - Belgio 41
MA - Marocco 40
VE - Venezuela 39
CO - Colombia 32
CZ - Repubblica Ceca 31
SA - Arabia Saudita 29
UZ - Uzbekistan 29
EG - Egitto 26
PH - Filippine 26
AE - Emirati Arabi Uniti 25
PE - Perù 24
CL - Cile 22
TN - Tunisia 22
KE - Kenya 21
PY - Paraguay 21
AZ - Azerbaigian 20
IL - Israele 20
KZ - Kazakistan 20
LT - Lituania 19
CR - Costa Rica 18
DZ - Algeria 16
HU - Ungheria 16
DO - Repubblica Dominicana 15
NP - Nepal 15
TH - Thailandia 15
IR - Iran 14
AT - Austria 13
JM - Giamaica 13
UY - Uruguay 13
BG - Bulgaria 12
HN - Honduras 11
PT - Portogallo 11
RO - Romania 11
SC - Seychelles 11
BJ - Benin 10
MY - Malesia 10
TT - Trinidad e Tobago 10
GR - Grecia 9
KG - Kirghizistan 9
LB - Libano 9
SV - El Salvador 9
BO - Bolivia 8
PA - Panama 8
SN - Senegal 8
TW - Taiwan 8
NI - Nicaragua 7
OM - Oman 7
AL - Albania 6
BH - Bahrain 6
SY - Repubblica araba siriana 6
ET - Etiopia 5
MM - Myanmar 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
DK - Danimarca 4
DM - Dominica 4
EU - Europa 4
GE - Georgia 4
GT - Guatemala 4
HR - Croazia 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
BW - Botswana 3
CY - Cipro 3
Totale 62.650
Città #
Santa Clara 5.346
Ashburn 3.659
Warsaw 2.754
Singapore 2.718
Fairfield 2.459
Hong Kong 1.636
Chandler 1.358
Dublin 1.315
Woodbridge 1.125
Seoul 1.099
Seattle 1.077
San Jose 1.034
Cambridge 976
Houston 954
Wilmington 801
Milan 745
Hefei 711
Beijing 690
Florence 508
Lawrence 443
Altamura 421
Los Angeles 415
Buffalo 414
Ann Arbor 413
Ho Chi Minh City 388
Princeton 359
Rome 344
Lauterbourg 320
The Dalles 311
Munich 293
Hanoi 282
Jacksonville 282
New York 274
Moscow 252
Paris 238
Boston 227
Mumbai 196
Council Bluffs 193
Shanghai 189
Melbourne 183
Helsinki 174
Medford 160
Dearborn 155
Kent 152
Boardman 150
Dallas 150
San Diego 143
São Paulo 136
Tokyo 124
Clifton 118
Naples 118
Frankfurt am Main 87
London 87
Toronto 87
Turin 87
Jakarta 86
Orem 80
Redondo Beach 73
Turku 73
Bologna 69
Guangzhou 68
Chicago 64
Abidjan 61
Bern 61
Montreal 60
Brooklyn 57
Falls Church 57
Barcelona 56
Phoenix 54
Da Nang 51
Denver 49
Chennai 48
Norwalk 46
Izmir 45
Abuja 44
Dong Ket 43
Miano 42
Bengaluru 39
Genoa 39
Stockholm 39
Brescia 37
Figino 37
Tianjin 37
Bari 36
Belo Horizonte 36
Brussels 36
San Francisco 36
Atlanta 35
Baghdad 34
Hillsboro 34
Palermo 34
Haiphong 33
Lappeenranta 33
Yubileyny 32
Johannesburg 31
Rio de Janeiro 31
Shenzhen 30
Pune 29
Catania 28
Tashkent 28
Totale 41.401
Nome #
Intravesical hyaluronic acid and chondroitin sulfate (Ialuril™) replenishment therapy for postradiation cystitis of prostate cancer: Results of a prospective pilot study 368
Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study 357
Quality of Life and Sexual Health in the Aging of PCa Survivors. 331
Head and neck reconstruction with pedicled flaps in the free flap era. 328
Hypofractionation in prostate cancer: radiobiological basis and clinical appliance. 323
Raccomandazioni cliniche per il carcinoma mammario 323
Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. 315
The Evolving Role of Ultrasound Guided Percutaneous Laser Ablation in Elderly Unresectable Breast Cancer Patients: A Feasibility Pilot Study 314
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. 308
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 297
A multiparametric method to assess the MIM deformable image registration algorithm 296
Therapeutic usability of two different fiducial gold markers for robotic stereotactic radiosurgery of liver malignancies: A pilot study 290
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 282
Multiple cutaneous angiosarcomas after breast conserving surgery and bilateral adjuvant radiotherapy: an unusual case and review of the literature. 273
Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study 271
Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases. 270
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 267
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis 267
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy inmetastatic breast cancer: a retrospective analysis. 267
Operator-dependent reproducibility of size measurements of small phantoms and lung nodules examined with low dose thin-section 262
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. 260
In Regard to Vaidya et al 259
Radiosensitivity in the breast cancer management scenario: Another step forward? 253
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 251
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 248
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 246
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 244
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 243
Prognosis of men with penile metastasis and malignant priapism: a systematic review. 240
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 239
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 238
ADAM: A breathing phantom for lung SBRT quality assurance 237
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 234
Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment 234
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 234
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial 234
ADAM phantom to test 4D medical imaging and dose delivery devices 231
CyberKnife stereotactic radiotherapy for isolated recurrence in the prostatic bed 226
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 226
Cervicoisthmic choriocarcinoma mimicking cesarean section scar ectopic pregnancy 224
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 224
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 221
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 221
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 219
Influence of age and subtype in outcome of operable liposarcoma 219
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 218
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 218
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 217
Auto-planning for VMAT accelerated partial breast irradiation 217
Current trends and outcomes of breast reconstruction following nipple-sparing mastectomy: results from a national multicentric registry with 1006 cases over a 6-year period 215
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 215
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 215
Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series 214
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 213
A case of metachronous double primary neuroendocrine cancer in pancreas/ileum and uterine cervix 212
Bladder Instillation Therapy With Hyaluronic Acid and Chondroitin Sulfate Improves Symptoms of Postradiation Cystitis: Prospective Pilot Study 212
Alternating intravenous and oral vinorelbine plus epirubicin with pegfilgrastim as neoadjuvant treatment of locally advanced breast cancer. 211
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 211
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two italian radiation oncology centers. I. the case of T1N0 disease. 210
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 209
Oral Lapacho-Based Medication: An Easy, Safe, and Feasible Support to Prevent and/or Reduce Oral Mucositis during Radiotherapy for Head and Neck Cancer 209
AIRO Breast Cancer Group Best Clinical Practice 2022 Update 208
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. 208
Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: a preliminary study. 208
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 208
Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial 208
Breast cancer in the elderly: treatment of 1500 patients. 207
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 207
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 206
Methodological approach to create an atlas using a commercial auto-contouring software 206
Interim PET after Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 205
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 205
The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation 204
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 204
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 204
Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. 204
Role of core needle biopsy in primary breast lymphoma 203
Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer. 202
Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer 201
Accelerated Partial Breast Irradiation with IMRT: New Technical Approach and Interim Analysis of Acute Toxicity in a Phase III Randomized Clinical Trial. 200
Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy 200
91P * DEFINITIVE CONCOMITANT RADIOCHEMOTHERAPY (RCT) TREATMENT FOR LOCALLY ADVANCED (LA) NON SMALL CELL LUNG CANCER (NSCLC): EVALUATION OF HEMATOLOGICAL AND ESOPHAGEAL TOXICITY IN THE RADIATION ONCOLOGY DEPARTMENT OF UNIVERSITY OF FLORENCE EXPERIENCE 200
Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy 199
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 199
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 196
Radiotherapy in the age of cancer immunology: Current concepts and future developments 195
A dosimetric comparison between CyberKnife and tomotherapy treatment plans for single brain metastasis 195
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 195
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 195
Use of tamoxifen in pT1a-pT1b, pN0 breast cancer. 195
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 194
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 193
Robotic Stereotactic Retreatment for Biochemical Control in Previously Irradiated Patients Affected by Recurrent Prostate Cancer 193
Stereotactic body radiotherapy with CyberKnife for cardiac malignancies 192
Docetaxel in Castration-Resistant Prostate Cancer: A Single-Centre Experience 192
Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo-radiotherapy 192
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 192
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 190
Adjuvant trastuzumab in breast cancer: experience from the University of Florence. 190
Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO) 190
Totale 23.115
Categoria #
all - tutte 185.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.233 58 175 189 130 71 111 83 198 98 111 390 619
2022/20236.166 565 1.252 262 348 451 1.051 775 414 685 63 170 130
2023/20242.592 109 252 368 137 166 365 116 581 53 134 206 105
2024/202517.072 623 1.685 1.048 2.739 4.892 1.977 304 985 824 534 632 829
2025/202620.715 2.095 2.581 1.747 1.687 2.271 729 2.500 1.043 1.322 1.415 780 2.545
2026/2027887 887 0 0 0 0 0 0 0 0 0 0 0
Totale 63.210